556.93

2.03% 11.07

After Hours: 558.00 1.07 +0.19%

Idexx Laboratories Inc (IDXX)

Overview News Price History Option Chain Financials Why IDXX Down? Discussions Forecast Stock Split

Idexx Laboratories Inc stock is traded at $556.93, with a volume of 485.74K. It is up +2.03% in the last 24 hours and up +0.81% over the past month. Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.

Previous Close:

$545.86

Open:

$550.14

24h Volume:

485.74K

Relative Volume:

0.75

Market Cap:

$43.88B

Revenue:

$4.45B

Net Income/Loss:

$1.10B

P/E Ratio:

40.98

EPS:

13.591

Net Cash Flow:

$1.06B

1W Performance:

+1.08%

1M Performance:

+0.81%

6M Performance:

-12.39%

1Y Performance:

-12.02%

1-Day Range:

$544.88

$557.66

1-Week Range:

$538.20

$575.56

52-Week Range:

$518.55

$769.98

Idexx Laboratories Inc Stock (IDXX) Company Profile

Name

Idexx Laboratories Inc

Sector

Healthcare (1080)

Industry

Diagnostics & Research (50)

Phone

(207) 556-0300

Address

ONE IDEXX DRIVE, WESTBROOK, ME

Employee

11,000

Twitter

@idexx

Next Earnings Date

2026-08-04

Latest SEC Filings

IDXX's Discussions on Twitter

Compare IDXX vs TMO, DHR, NTRA, A

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
IDXX Idexx Laboratories Inc	556.93	44.29B	4.45B	1.10B	1.06B	13.59
TMO Thermo Fisher Scientific Inc	629.27	232.03B	45.20B	6.87B	6.75B	18.19
DHR Danaher Corp	218.85	151.78B	24.78B	3.68B	5.29B	5.1743
NTRA Natera Inc	332.03	46.86B	2.50B	-226.32M	71.51M	-1.6412
A Agilent Technologies Inc	159.00	43.89B	7.23B	1.41B	1.09B	4.979

Idexx Laboratories Inc Stock (IDXX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Apr-15-26	Initiated	Citigroup	Neutral
Dec-09-25	Initiated	Barclays	Overweight
Oct-31-25	Upgrade	Stifel	Hold → Buy
Oct-01-25	Initiated	UBS	Neutral
Aug-05-25	Reiterated	BTIG Research	Buy
Jul-01-25	Initiated	Jefferies	Buy
Dec-02-24	Initiated	Leerink Partners	Outperform
Jul-25-24	Initiated	BTIG Research	Buy
Jan-30-24	Downgrade	Piper Sandler	Overweight → Neutral
Dec-07-23	Initiated	Exane BNP Paribas	Outperform
Dec-04-23	Upgrade	Cleveland Research	Neutral → Buy
Aug-02-23	Downgrade	Atlantic Equities	Overweight → Neutral
Jul-25-22	Downgrade	Stifel	Buy → Hold
Jul-21-22	Upgrade	Goldman	Neutral → Buy
Jul-12-22	Initiated	Piper Sandler	Overweight
May-05-22	Downgrade	BofA Securities	Buy → Neutral
Feb-08-22	Initiated	Atlantic Equities	Overweight
Nov-18-21	Initiated	Morgan Stanley	Overweight
Aug-05-21	Resumed	Credit Suisse	Outperform
Jul-12-21	Downgrade	Guggenheim	Buy → Neutral
Feb-17-21	Initiated	Barclays	Overweight
Sep-09-19	Initiated	Goldman	Neutral
May-23-19	Initiated	Guggenheim	Buy
Nov-02-18	Reiterated	BofA/Merrill	Buy
May-07-18	Reiterated	Stifel	Buy
Jan-16-18	Initiated	Piper Jaffray	Overweight
Aug-23-17	Upgrade	BofA/Merrill	Neutral → Buy
Jul-28-17	Upgrade	CL King	Neutral → Buy
Feb-03-17	Downgrade	Feltl & Co.	Hold → Sell
Sep-29-16	Resumed	BofA/Merrill	Neutral
Aug-16-16	Reiterated	Stifel	Buy
Aug-03-16	Upgrade	Northcoast	Sell → Neutral
Jul-20-16	Reiterated	Canaccord Genuity	Buy
Apr-19-16	Reiterated	Canaccord Genuity	Buy
Apr-01-16	Initiated	CL King	Neutral
Mar-21-16	Reiterated	Stifel	Buy
Feb-04-16	Initiated	Credit Suisse	Outperform
Oct-29-15	Reiterated	Stifel	Buy
Aug-28-15	Downgrade	Raymond James	Outperform → Mkt Perform
Aug-13-15	Reiterated	Stifel	Buy
Jul-23-15	Reiterated	Canaccord Genuity	Buy

View All

Idexx Laboratories Inc Stock (IDXX) Latest News

09:54 AM

Is it a Prudent Move to Retain IDEXX Stock in Your Portfolio Now? - TradingView

09:54 AM

Aug 20, 2026

IDEXX launches first dual-species point-of-care NT-proBNP test for cardiac disease in cats and dogs - DVM360

Aug 20, 2026

IDEXX Laboratories Inc. stock underperforms Thursday when compared to competitors - MarketWatch

Aug 20, 2026

Rationale Behind Baron Focused Growth Fund’s IDEXX Laboratories (IDXX) Holding - Yahoo Finance

Aug 20, 2026

Flossbach Von Storch SE Invests $9.09 Million in IDEXX Laboratories, Inc. $IDXX - MarketBeat

Aug 20, 2026

Danske Bank A S Buys New Stake in IDEXX Laboratories, Inc. $IDXX - MarketBeat

Aug 20, 2026

Aug 19, 2026

Resilient IDEXX Laboratories stock trades in the mid-$550s as investors weigh premium valuation and - Ad-hoc-news.de

Aug 19, 2026

Will In-Clinic Cardiac Testing Expansion via Catalyst proBNP Test Change IDEXX Laboratories' (IDXX) Narrative - Sahm

Aug 19, 2026

Aug 18, 2026

IDXX (IDEXX Laboratories) Cash Flow from Operations : $1,372 Mil (TTM As of Jun. 2026) - GuruFocus

Aug 18, 2026

IDEXX Laboratories Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch

Aug 18, 2026

IDEXX Laboratories stock holds above the mid-$540s as valuation stays demanding - Ad-hoc-news.de

Aug 18, 2026

IDXX (IDEXX Laboratories) Cash From Discontinued Investing Activities : $0 Mil (TTM As of Jun. 2026) - GuruFocus

Aug 18, 2026

Tranche Update on IDEXX Laboratories, Inc.'s Equity Buyback Plan announced on August 13, 1999. - marketscreener.com

Aug 18, 2026

Plato Investment Management Ltd Takes $1.48 Million Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat

Aug 18, 2026

IDEXX Labs Executing, But Valuation Continues To Weigh On That Execution (NASDAQ:IDXX) - Seeking Alpha

Aug 18, 2026

IDEXX Laboratories (IDXX) Could Be 22% Undervalued As New Cardiac Test Expands Its Reach - Sahm

Aug 18, 2026

Aug 17, 2026

Weekly Recap: AI diagnostics expansion and Barclays trims target to $710 - TradingView

Aug 17, 2026